Stock Market

Best Midcap: Choose 6 strong midcap stocks with Anil Singhvi, will get bumper returns in short to long term

Talk about the last 1 year, this segment has performed brilliantly. Due to the improving economy and better macro conditions in the country, there is going to be good growth in midcap companies in the future as well.

Best Midcap Stocks to Buy: The midcap segment has always been popular among domestic retail investors. The reason for this is that there are more than one and more options for investment in it. If you are also looking for quality stocks to invest in the midcap category, then today’s list is ready. Even after a long rally in the midcap category, many stocks are trading at attractive valuations. The fundamentals of these stocks are looking strong, while their valuations are also strong. These can further give high returns to the investors in the short term to the long term. Today the list of these stocks includes BEML, BSE, Aster DM Health, JOCIL, Gufic Bio and Indraprashtha Medical. In a conversation with dgmartpro Business Managing Editor Anil Singhvi, Trade Swift director Sandeep Jain and market expert Mudit Goyal have selected them as their choice. You too can earn good profits by investing money in them.

Liked by Mudit Goyal

Long Term: BEML

Mudit Goyal has advised to invest in BEML for long term. For the share, he has given a target of Rs 1800 to Rs 1850. Whereas it is advisable to put a stop loss at Rs 1600. The consolidation happened after the big move in the stock. Now the stock is looking better on the chart. There seems to be a lot of momentum coming from here.

Positional: BSE

Mudit Goyal has advised to invest in BSE for positional pick. For the share, he has given a target of Rs 1550 to Rs 1580. At the same time, it is advised to put a stop loss at Rs 1380. Indication for the stock is looking good on the chart. From here it can be very fast.

Short Term: Aster DM Health

For the short term, Mudit Goyal has advised to invest in Aster DM Health. A target of Rs 210 has been given for the stock, while it is advised to put a stop loss at Rs 190. After the consolidation, the kind of chart structure that has now been made, now there will be an uptrend.

Liked by Sandeep Jain

Long Term: JOCIL

Sandeep Jain advises to invest in JOCIL for long term. For the stock, he has given a target of Rs 250 to Rs 270. The stock has not moved much in the past days. The risk reward ratio for the stock is looking good. Dividend yield record is good.

Positional: Gufic Bio

Sandeep Jain has recommended investment in Gufic Bio for a positional pick. He has given a target of Rs 230 for the share. Whereas it is advised to put a stop loss at Rs 185. The fundamentals of the company are good. The company supplies to large hospital chains. The company also manufactures herbal products. There has been great growth in the last 3 years.

Short Term: Indraprashtha Medical

Sandeep Jain has advised to invest in Indraprashtha Medical for short term. He has given a target of Rs 85 for the share. This stock has also been an underperformer. The risk reward ratio is better.

,

Show More

Related Articles

Leave a Reply

Back to top button